Skip to content
AnalystLens

PROCTER & GAMBLE Co Annual Report, Year Ended Jun 30, 2022

Filing Date
Filed August 5, 2022
Period End
June 30, 2022
Security
PG
One revenue dollarkept$0.18
In the record · 2016–202610-K1210-Q328-K224

PG filed 12 annual reports (10-K), 32 quarterly reports (10-Q) and 224 current reports (8-K) between 2016 and 2026.

  1. Leadership change8-K · Aug ’21Aug ’21
  2. Leadership change8-K · Jul ’26Jul ’26

Summary

Summary of the 10-K filed August 5, 2022. Cited figures are marked; the original filing is the authoritative source.

Procter & Gamble's 2022 10-K filing details a year of resilience and strategic execution amidst a challenging macroeconomic environment.

The company reported a 5% increase in net sales to $80.2 billiona, driven by a 2% rise in unit volume and a 4% positive impact from pricing, which helped offset unfavorable foreign exchange impacts. Despite a 1% decrease in operating income due to margin compression, net earnings grew by 3% to $14.8 billion, with diluted EPS rising 6% to $5.81. The company demonstrated strong adjusted free cash flow productivity of 93%, underscoring its ability to generate cash.

Key segments like Health Care and Fabric & Home Care showed robust organic sales growth, indicating strong brand performance and consumer demand for essential products. The filing highlights P&G's commitment to shareholder returns, with a 66th consecutive annual dividend increase and $10 billionb in share repurchases during the fiscal year. Management remains focused on delivering long-term value through a strategy emphasizing product superiority, productivity improvements, and constructive disruption.

The company is navigating cost pressures from commodities and transportation through pricing actions and cost-saving initiatives. P&G is also actively managing risks associated with global economic volatility, geopolitical events like the Russia-Ukraine war, and supply chain disruptions, while continuing to invest in innovation and talent.

Key Highlights

  1. Net sales increased 5% to $80.2 billion, driven by a 2% volume increase and 4% favorable pricing, successfully navigating foreign exchange headwinds.
  2. Diluted EPS grew 6% to $5.81, reflecting a 3% increase in net earnings to $14.8 billion, demonstrating profitable growth.
  3. Generated $13.8 billion in Adjusted Free Cash Flow, with a strong productivity of 93%, highlighting robust cash generation capabilities.
  4. The company returned $18.8 billion to shareholders through dividends ($8.8 billion) and share repurchases ($10 billion), underscoring commitment to shareholder returns.
  5. Health Care and Fabric & Home Care segments showed strong organic sales growth, indicating resilience and consumer preference for core product categories.
  6. P&G continues to prioritize innovation and productivity, with plans to invest in sustainability, digital acumen, supply chain capabilities, and talent development.
  7. The company is actively managing significant macroeconomic risks including inflation, foreign exchange volatility, and geopolitical instability (e.g., Russia-Ukraine war) through strategic pricing and cost management.

Follow one dollar

Of each $1.00 of revenue in FY2022, Procter & Gamble Co kept $0.18.

  1. Revenue$80.19B100.0%
  2. Cost of revenue−$42.16B52.6%
  3. Gross profit$38.03B47.4%
  4. Operating costs−$20.22B25.2%
  5. Operating income$17.81B22.2%
  6. Interest, other & tax−$3.07B3.8%
  7. Net income$14.74B18.4%
Computed from 10-KFY2022filed August 5, 2022Computed from this filing’s revenue, gross profit, operating income and net income · right columngrey figure: share of revenue

Financial Statements

FY2022 against FY2021

Line itemFY2022FY2021Change
Revenue$80.19B$76.12B+5.3%
Cost of Revenue$42.16B$37.11B+13.6%
Gross Profit$38.03B$39.01B−2.5%
R&D Expenses$2.00B$1.90B+5.3%
SG&A Expenses$20.22B$21.02B−3.8%
Operating Income$17.81B$17.99B−1.0%
Interest Expense$439.00M$502.00M−12.5%
Net Income$14.74B$14.35B+2.7%
EPS (Basic)$6.00$5.69+5.4%
EPS (Diluted)$5.81$5.50+5.6%
Shares Outstanding (Basic)2.41B2.47B−2.3%
Shares Outstanding (Diluted)2.54B2.60B−2.4%

Frequently Asked Questions

  1. What was the overall financial performance of Procter & Gamble in fiscal year 2022?

    In fiscal year 2022, Procter & Gamble reported a 5% increase in net sales to $80.2 billion and a 6% increase in diluted EPS to $5.81. Net earnings grew by 3% to $14.8 billion. The company generated strong adjusted free cash flow of $13.8 billion with 93% productivity, demonstrating effective cash generation despite facing challenges like increased commodity costs and unfavorable foreign exchange.

  2. How did the company manage cost pressures and inflation?

    P&G addressed cost pressures from commodities and transportation by implementing pricing actions, which contributed a 4% increase to net sales. They also focused on productivity improvements and cost-saving projects across the organization to mitigate these impacts and maintain margins.

  3. What is the company's strategy for future growth and value creation?

    P&G's strategy is centered on delivering irresistible superiority across product performance, packaging, brand communication, retail execution, and value. Key focus areas for future performance include leveraging environmental sustainability, increasing digital acumen, developing advanced supply chain capabilities, and fostering an inclusive employee value equation to attract and retain top talent.

  4. What risks does Procter & Gamble identify as significant challenges?

    The company highlights several risks, including macroeconomic volatility (economic slowdowns, inflation), foreign currency fluctuations, geopolitical instability (such as the Russia-Ukraine War), supply chain disruptions, competitive pressures, and risks associated with its reputation and brand equity. They also note the potential impact of changing political conditions and regulatory requirements.